Emerging new Company veriNOS pharmaceuticals, established in October 2022, Led by CEO, Christian Wandersee and CMO Professor John Stover, provides an update on its revival of late-stage drug candidate ronopterin for the treatment of Traumatic Brain Injury (TBI). Ronopterin is the first and only iNOS inhibitor which has demonstrated repeated signs of neuroprotection in TBI […]
February moves 2023 Investment Firms Patient Square Capital has closed its inaugural fund with $3.9 billion BlueBox Asset Management launched its Precision Medicine Fund Banking & Analysts Susie Jana has left Shore Capital Mette Kirstine Agger has left Lundbeckfonden Ventures, now serves as a strategic advisor Daniela Begolo has joined EQT Life Sciences as a […]
Each year, Rare Disease Day aims to raise awareness of rare diseases and encourage positive change to patients’ lives. A disease is considered rare when it affects fewer than 1 in 2,000 people and there are 300 million people with rare diseases across the world.1 On Rare Disease Day 2023, we want to celebrate the […]
Co-founder and Chief Scientific Officer at Leucid Bio, Dr John Maher is revolutionising Chimeric Antigen Receptor (CAR) T-cell therapy, by designing CARs that are more powerful than predecessors and tough enough to tackle solid tumours. Dr Maher began his academic career at Trinity College, Dublin and has held numerous clinical, research and teaching positions at […]
The sad death at the young age of 54 of David Jolicoeur, otherwise known as Trugoy the Dove, one of the founders of hip hop legends De La Soul, has helped to highlight to a wider audience the profound impact that congestive heart failure can have. David was a long term sufferer from this disease. […]